Literature DB >> 17416955

Surgical approaches used in the reconstruction of the eyelids after excision of malignant tumors.

Kaan Gündüz1, Sibel Demirel, Ilhan Günalp, Burcu Polat.   

Abstract

The choice of reconstructive technique for eyelid defects after malignant tumors was based on tumor location and defect size after tumor excision. Treatments included direct closure for defects measuring less than 25%, Tenzel flap for defects measuring 25-50%, lid-sharing procedures for defects measuring more than 50%, skin grafts for tumors affecting the inner canthus advancement flap for outer canthus tumors, and orbital exenteration for malignant tumors demonstrating orbital invasion.

Entities:  

Mesh:

Year:  2006        PMID: 17416955     DOI: 10.1007/s12009-006-0006-1

Source DB:  PubMed          Journal:  Ann Ophthalmol (Skokie)        ISSN: 1530-4086


  5 in total

1.  Clinicopathologic features and prognostic factors of malignant eyelid tumors.

Authors:  Chang-Jun Wang; Hui-Na Zhang; Han Wu; Xin Shi; Jia-Jun Xie; Jin-Jing He; Koung-Hoon Kook; Sang-Yeul Lee; Juan Ye
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

Review 2.  Facial Skin Cancer Reconstruction.

Authors:  Jesse D Meaike; Ryan M Dickey; Elizabeth Killion; Erica L Bartlett; Rodger H Brown
Journal:  Semin Plast Surg       Date:  2016-08       Impact factor: 2.314

3.  Eyelid Malignancies- Always Quite Challenging.

Authors:  Arumugham Balasubramanian; Narayanasamy Subbaraju Kannan
Journal:  J Clin Diagn Res       Date:  2017-03-01

4.  Total lower lid reconstruction: clinical outcomes of utilizing three-layer flap and graft in one session.

Authors:  Mohammad Taher Rajabi; Fatemeh Bazvand; Seyedeh Simindokht Hosseini; Ali Makateb; Mohammad Bagher Rajabi; Syed Ziaeddin Tabatabaie; Yalda Abrishami
Journal:  Int J Ophthalmol       Date:  2014-06-18       Impact factor: 1.779

5.  Frontal axial pattern flap combined with hard palate mucosa transplant in the reconstruction of midfacial defects after the excision of huge basal cell carcinoma.

Authors:  Junliang Wu; Yong Qing; Ying Cen; Junjie Chen
Journal:  World J Surg Oncol       Date:  2018-06-29       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.